A Single Ascending Dose Study of BMS-650032 in HCV Infected Subjects

Inclusion Criteria: * Chronically infected with HCV genotype 1 * Treatment naive or treatment non-responders or treatment intolerant * HCV RNA viral load of ≥10\*5 IU/mL * BMI 18 to 35kg/m² Exclusion Criteria: * Any significant acute or chronic medical illness which is not stable or is not controlled with medication and not consistent with HCV infection * Major surgery within 4 weeks of study drug administration and any gastrointestinal surgery that could impact the absorption of study drug * Co-infection with HIV or HBV * Women of childbearing potential